MEDIA ROOM 


CONTACT

Jonathan Keehner / Julie Oakes
Joele Frank, Wilkinson Brimmer Katcher
212-355-4449


 
 

Press Releases


2024


30 May 2024

Celcuity Inc. Announces Plan to Initiate a Phase 3 Clinical Trial for Gedatolisib as First-Line Treatment for HR+/HER2- Advanced Breast Cancer and Secures Approximately $62 Million Debt Financing


2022



2021



2020



2019



2018



2017



2016



2015


7 October 2015

New York – (Business Wire)


 

Media Coverage




2018



2017



2016


28 September 2016

THE NEW YORK TIMES - DEALBOOK

Perella Weinberg Partners Split Off to Open Investment Firm